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SUMMARY
In dibutyryl-cAMP-differentiated HL-60 cells, histamine H1 and
formyl peptide receptors mediate increases in the cytosolic
Ca2 concentration ([Ca21) via pertussis toxin-sensitive G pro-
teins of the G family. We compared the effects of 2-(3-chloro-
phenyl)-histamine (CPH) [2-[2-(3-chlorophenyl)-1 H-imidazol-4-yI]
ethanamine], one of the most potent and selective H1 receptor
agonists presently available, with those of histamine and N-
formyl-L-methionyl-L-Ieucyl-L-phenylalanine (fMLP) in these cells.
CPH increased [Ca21 through Ca2 mobilization and Ca2 influx.
Unlike histamine-induced rises in [Ca2], those induced by CPH
were not desensitized in a homologous manner, and there was
no cross-desensitization between CPH and histamine. Like
fMLP, CPH activated phospholipases C and D, tyrosine phos-
phorylation, superoxide anion formation, and azurophilic granule
release. The effects of CPH on [Ca2j, phospholipase D, and
superoxide anion formation were inhibited by pertussis toxin.
CPH and fMLP stimulated high affinity GTP hydrolysis by G
proteins in HL-60 membranes. They also enhanced binding of
guanosine-5’-O-(3-thio)triphosphate and GTP azidoanilide to,
and cholera toxin-catalyzed ADP-ribosylation of, G protein a
subunits. Histamine receptor antagonists did not inhibit the stim-
ulatory effects of CPH, and CPH did not reduce fMLP binding in
HL-60 membranes. Our data suggest that CPH activates G
proteins in HL-60 cells through a receptor agonist-like mecha-
nism that is, however, independent of known histamine receptor
subtypes and formyl peptide receptors. CPH may be an agonist
at an as yet unknown histamine receptor subtype or, by analogy
with other cationic-amphiphilic substances, may activate G pro-
teins directly. Future studies will have to take into consideration
the fact that CPH, in addition to activating H1 receptors, may
show other, most unexpected, stimulatory effects on G protein-
mediated signal transduction processes.
Dibutyryl-cAMP-differentiated HL-G0 leukemic cells possess
receptors for the chemotactic peptide fMLP (1-5). Agonist-
occupied formyl peptide receptors activate PTX-sensitive G
proteins of the G, family, leading to activation of phospholipase
C (2, 6, 7). This enzyme catalyzes the formation of inositol
trisphosphate, which mobilizes Ca2 from intracellular stores
(2). Additional events in the cellular activation process caused
by fMLP are the stimulation of Ca2 influx via nonselective
cation channels, stimulation of phospholipase D, and tyrosine
phosphorylation of 100/110-kDa proteins (2, 3, 8, 9). Ulti-
mately, stimulation of HL-60 cells by fMLP results in the
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activation of the O2-forming NADPH oxidase and azurophilic
granule release (1-5).
In addition to formyl peptide receptors, dibutyryl-cAMP-
differentiated HL-60 cells possess H1 receptors coupled to G,
proteins and, possibly, to PTX-insensitive G proteins (2). H1
receptors mediate activation of phospholipase C and of nonse-
lective cation channels (2). However, unlike fMLP, HA does
not activate tyrosine phosphorylation and shows no stimulatory
effects on O2 formation and azurophilic granule release, i.e.,
HA is an incomplete secretagogue (2). Thus, the functional
relevance of H1 receptors in dibutyryl-cAMP-differentiated
HL-60 cells remains obscure.
In the past, the functional characterization of H1 receptors
was hampered by the lack of availability of potent and selective
agonists for these receptors (10, 1 1). Recently, we reported on
the synthesis of a series of substituted 2-phenyihistamines (12).
ABBREVIATIONS: fMLP, N-formyl-L-methionyl-L-leucyl-L-phenylalanine; [Ca2], cytosolic Ca2 concentration; CB, cytochalasin B; CPH, 2-(3-
chlorophenyl)histamine; CTX, cholera toxin; GTP-yS, guanosine-5’-O-(3-thio)triphosphate; HA, histamine; PTX, pertussis toxin; HEPES, 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid; EGTA, ethylene glycol bis(/3-aminoethyl ether)-N,N,N’,N’-tetraacetic acid; SOS, sodium dodecyl
sulfate.
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Fig. 1 . Concentration-response
curves for CPH- and HA-induced
rises in [Ca2J in HL-60 cells and
effects of PTX. HL-60 cells were
treated with PTX or carrier (control)
as described in Experimental Pro-
cedures. Thereafter, cells were her-
vested and loaded with fura-2/ace-
toxymethyl ester, and the effects of
CPH and HA at various concentra-
tions on [Ca2j were assessed as
described in Experimental Proce-
dures. #{149},Control cells; #{149},PTX-
treated cells. PTX had no effect on
basal [Ca2] in HL-60 cells.
6 5 47 6 5 4
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Among these substances, CPH is one of the most potent and
selective H1 receptor agonists presently available (12). In the
guinea pig ileum, CPH activates H1 receptors with potency and
effectiveness comparable to those of HA (12). In the hamster
ductus deferens smooth muscle cell line DDT1MF-2, CPH is a
potent partial H1 receptor agonist (13). Fig. 1 shows the struc-
tural formulae of HA and CPH.
The original aim of our present study was to clarify the
functional relevance of H1 receptors in dibutyryl-cAMP-differ-
entiated HL-60 cells, using CPH as a tool. Most unexpectedly,
however, we noticed several differences in the effects of CPH
and HA, suggesting that CPH does not act as a H1 receptor
agonist in HL-60 cells. We discuss the possibilities that CPH
either is an agonist at an as yet unknown HA receptor subtype
or, by analogy with other cationic-amphiphilic substances (14,
15), activates G, proteins directly.
Experimental Procedures
Materials. CPH was synthesized as described (12). Stock solutions
of CPH (30 mM) were prepared in distilled water and were stored at
20*. Lipids were from Sigma Chemie (Deisenhofen, Germany). PTX
was from List Biological Laboratories (Campbell, CA). [9,10-3HJOleic
acid (2-10 Ci/mmol) and [S]GTP’yS (1200-1500 Ci/mmol) were
obtained from New England Nuclear (Bad Homburg, Germany).
Sources of other materials have been described elsewhere ( 1-5, 7-9,
16-19).
Cell culture and membrane preparation. HL-60 cells were
grown in suspension culture and were differentiated towards neutro-
phil-like cells with dibutyryl-cAMP (0.2 mM) for 48 hr (1). For deter-
mination of the activity of high affinity GTPase, for fMLP binding,
and for photolabeling, HL-60 membranes were prepared as described
(18). PTX (1 g/ml) or its carrier (control) was added to cell cultures
24 hr before experiments or membrane preparation. Under these con-
ditions, >98% of G1 protein a subunits were ADP-ribosylated (4).
Measurement of [Ca24] and Mn2 influx. [Ca211 was determined
using the fluorescent dye fura-2, as described (2). Fluorescence of HL-
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60 cells (1.0 x 106 cells in 2 ml) was determined at 37’, with constant
stirring at i0 rpm, using a Ratio II spectrofluorometer (Aminco, Silver
Spring, MD). Cells were incubated for 3 mm in the presence of various
substances before the addition of stimuli. The excitation and emission
wavelengths were 340 and 500 nm, respectively. Unless stated other-
wise, experiments were performed in the presence of 1 mM CaCl2.
Desensitization of rises in [Ca2]1 was determined according to the
protocol described by Schwaner et aL (17). Mn2 influx was assessed
according to the method of Seifert et al. (2).
fMLP binding assay. [3H]fMLP binding was determined as de-
scribed (5). Reaction mixtures (100 Ml) contained 30 g of membrane
protein from HL-60 cells, [3H]fMLP (3 nM), and CPH at various
concentrations or solvent (control). Reactions were conducted for 30
mm at 25* and stopped by rapid filtration. Nonspecific binding was
determined in the presence of 10 MM fMLP and was <10% of total
binding.
Assay for phosphoinositide degradation. Phosphoinositides in
HL-60 cells were labeled by incubation with 2-5 MCi/mI myo-[2-3HJ
inositol for 48 hr (2). HL-60 cells (1 x 10e cells in 200 Ml) were suspended
in buffer and were exposed to CPH (100 MM) or solvent (control) for
30 sec at 37’ (2). Experiments were carried out in the absence of LiCl.
Stopping of reactions, extraction oflipids, and detection of radioactivity
by scintillation counting were performed as described (2).
Assay for phosphatidylethanol formation. For labeling of phos-
pholipids, HL-60 cells were seeded at 0.5 x 106 cells/ml in culture
medium and were incubated with 25-50 MCi/ml [9,10-3H]oleic acid for
16-20 hr. Labeled cells were centrifuged at 250 x g for 10 mm at 20
and were resuspended at 0.5 x 10e cells/ml in a buffer consisting of 125
mM NaC1, 0.7 mM MgC12, 0.5 mM EGTA, 10 mM glucose, 0.1% (w/v)
fatty acid-free bovine serum albumin, and 25 mM HEPES/NaOH, pH
7.2. Centrifugation was repeated. Cells were resuspended at 2.5-5.0 x
106 cells/ml. Reaction mixtures (50 Ml) contained 0.5-1.0 x i0 cells in
the aforementioned buffer supplemented with CaC12 (free Ca2 concen-
tration, 1 mM) and were preincubated for 15 mm at 37’. Reactions
were initiated by the simultaneous addition of CB (1 g/ml), 0.5% (v/
v) ethanol, and stimuli or solvent (control). Reactions were terminated
by the addition of 150 ILl of CHC13/CH3OH/concentrated acetic acid
(100:200:4, v/v/v). Phase separation was achieved by addition of 50 Ml
of CHC13 and 50 ILl of water. Samples were centrifuged at 3000 x g for
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30 mm at 4’. The upper phase was removed, and 50 Ml of the organic
phase were spotted onto Whatman LKGD thin layer chromatography
plates. Nonradioactive phosphatidylethanol was synthesized as de-
scribed (20) and was added to thin layer chromatography plates. Plates
were developed in a system consisting of the upper phase of ethyl
acetate/isooctane/concentrated acetic acid/water (65: 10: 15:50, v/v/v).
Phosphatidylethanol was detected by exposure to iodine vapor, and the
areas corresponding to phosphatidylethanol were scraped off after
sublimation of iodine. Lipids were eluted from the silica gel with 0.5
ml of CH3OH/1 M HC1 (20:1, v/v), and radioactivity was determined
in a liquid scintillation counter.
Assay for tyrosine phosphorylation. HL-60 cells (1 x 106 cells
in 40 Ml) were suspended in buffer at 37’ and were incubated for 3 mm
in the absence or presence of CB ( 1 g/ml) before exposure to stimuli
for 1 or 3 mm (8). Stopping of reactions and immunological detection
of tyrosine-phosphorylated proteins were performed as described by
Offermanns et a!. (8).
Assay for 02 formation in HL-60 cells. 02 formation was
monitored at 550 nm by continuous measurement of ferricytochrome c
reduction inhibitable by superoxide dismutase, using an Uvikon 810
dual-beam spectrophotometer (Kontron, Eching, Germany) (1). HL-60
cells (2.5 x i0 cells in 500 ILl) were incubated for 3 mm at 3T in the
absence or presence of CB (1 g/ml) before the addition of stimuli.
Assays for the release of $-glucuronidase and lactate dehy-
drogenase. Enzyme release was determined as described (4). HL-60
cells (5 x i0 cells in 500 /.Ll) were suspended in buffer at 3T and were
incubated for 5 mm in the presence of CB (1 g/ml) before exposure
to stimuli for 10 mm. Stopping of reactions and determination of the
activities of /3-glucuronidase and lactate dehydrogenase in supernatant
fluids of reaction mixtures and in cell lysates were performed as
described (21).
GTPase assay. GTP hydrolysis was determined as described (5).
Reaction mixtures (100 Ml) contained HL-60 membranes (3.0-7.0 g of
protein/tube), 0.5 MM [-y-32P]GTP (0.1 MCi/tube), 0.5 mM MgCl2, 0.1
mM EGTA, 0.1 mM ATP, 1 mM adenosine-5’-(fi,-y-imido)triphosphate,
5 mM creatine phosphate, 40 g of creatine kinase, 1 mM dithiothreitol,
and 0.2% (w/v) bovine serum albumin in 50 mM triethanolamine-HC1,
pH 7.4, with substances at various concentrations. Reactions were
conducted for 15 mm at 25*. Low affinity GTPase activity was deter-
mined in the presence of GTP (50 MM) and amounted to <5% of total
GTPase activity. The determination of GTP hydrolysis in N-ethyl-
maleinimide-treated HL-60 membranes was performed as described
(9).
GTP’YS binding assay. [SJGTP-yS binding was assessed accord-
ing to the method of Gierschik et aL (22), with modifications. In brief,
reaction mixtures (100 Ml) contained HL-60 membranes (3.0-5.0 Mg of
protein/tube), 0.4 nM [SJGTP-yS, 5 mM MgCl2, 1 mM EDTA, 150 mM
NaC1, 0.5 MM GDP, 1 mM dithiothreitol, and 0.2% (w/v) bovine serum
albumin in 50 mM triethanolamine-HC1, pH 7.4. Reaction mixtures
additionally contained various substances. Reactions were conducted
for 30 mm at 25’ and were terminated by rapid filtration through
cellulose nitrate BA 85 filters (Schleicher & Schuell, Dassel, Germany),
followed by two washes with 5 ml of buffer (4*) consisting of 5 mM
MgCl2, 1 fliM EDTA, and 50 mM triethanolamine-HC1, pH 7.4. Non-
specific binding was determined in the presence of 10 MM GTP-yS and
was <1% of total binding.
Assay for photolabeling of membrane proteins. HL-60 mem-
branes (50 g of protein in 60 Ml) were incubated at 30* in a buffer
consisting of 0.1 mM EDTA, 5 mM MgC12, 1 mM benzamidine, 10 MM
GDP, and 30 mM HEPES/NaOH, pH 7.4. After exposure to various
substances for 3 mm, samples were incubated for another 3 mm with
10 nM [a-32P]GTP azidoanilide (1 MCi/tube). Stopping of reactions and
irradiation of samples were performed as described (7).
Assay for CTX-catalyzed ADP-ribosylation of membrane
proteins. For these experiments, membranes were prepared as de-
scribed by Klinker et aL (9). Reaction mixtures (50 Ml) contained
membranes from about 1 x iO HL-60 cells, 3 MM [32P]NAD (1 MCi/
tube), 2.5 mM MgC12, 1 mM ATP, 0.2% (w/v) bovine serum albumin, 2
Mg of activated CTX, and 0.1 M potassium phosphate, pH 7.4, with
various substances. Reactions were conducted for 60 mm at 30’ (9).
Miscellaneous methods. Cell viability was assessed by trypan blue
dye exclusion (21). Protein was determined according to the method of
Lowry et aL (23). [-y-32PJGTP was prepared as described (24). [a-32P]
GTP azidoanilide was synthesized according to the method of Offer-
manns et al. (19). [32PJNAD was synthesized according to the method
of Cassel and Pfeuffer (25). SDS-polyacrylamide gel electrophoresis
and autoradiography were performed as described by Rosenthal et al.
(16). Autoluminographs of SDS gels from tyrosine phosphorylation
experiments and autoradiographs of SDS gels from photolabeling ex-
periments were subjected to densitometric analysis using a LKB Ul-
troscan densitometer. The statistical significance of the effects of
stimuli on inositol phosphate and phosphatidylethanol formation was
assessed using the Wilcoxon test.
Data reproducibility. Data shown in Figs. 1, 5B, 6, and 7 and
Tables 1, 2, and 4 are the means ± standard deviations of assay
quadruplicates. Similar results were obtained in at least three inde-
pendent experiments. Data shown in Table 3 are the means ± standard
deviations of three independent experiments. Data shown in Figs. 2-4,
5A, and 8 are representative of at least three independent experiments.
Results
Concentration-response curves for the stimulatory effects of
CPH and HA on [Ca2]1 in HL-60 cells are shown in Fig. 1. HA
increased [Ca2] with an EC50 of 5 zM and a maximum at 30-
100 MM. In PTX-treated cells, the stimulatory effects of HA on
[Ca211 were partially inhibited. CPH increased [Ca2]1 with an
ECso of about 50 MM and a maximum at 75-100 MM. At a
maximally effective concentration, CPH was by approximately
45% less effective than HA in increasing [Ca2]1. Treatment of
HL-60 cells with PTX abolished the rises in [Ca2]1 caused by
CPH.
The effects of the H1 receptor antagonists clemastine, chlor-
pheniramine, and diphenhydramine (10, 11), of the H2 receptor
antagonists cimetidine and famotidine (10, 26), and ofthe dual
H1/H3 receptor antagonist impromidine (2, 10) on CPH- and
HA-induced rises in [Ca2]1 in HL-60 cells are summarized in
Table 1. H1 but not H2 receptor antagonists inhibited HA-
induced rises in [Ca2]1. In contrast, none of the HA receptor
antagonists studied had an inhibitory effect on CPH-induced
rises in [Ca2’].
We studied the effect of CPH on binding of fMLP (3 nM) in
TABLE 1
Effects of HA receptor antagonists on HA- and CPH-induced rises
in (Ca211 in HL-60 cells
HL-60 cells were harvested and loaded with fura-2/acetoxymethyl ester, and the
effects of HA and CPH (1 00 MM each) on [ca2] were assessed in the absence or
presence of various HA receptor antagonists, as deathbed in Experimental Pro-
cedures. HA receptor antagonists or solvent (control) was added to cells 3 mm
before HA or cPH. me concentration of clemastine, chiorpheniramine, diphenhy-
dramine, cimetidine, and famotidine was 10 MM, and that of impromidine was 100
MM. HA receptor antagonists by themselves had no effect on [ca2].
Increasein ICa2i
Addition
HA CPH
flM
Solvent (control) 385 ± 34 205 ± 23
Clemastine 0 198 ± 22
Chlorpheniramine 0 21 0 ± 10
Oiphenhydramine 12 ± 8 199 ± 19
Cimetidine 365 ± 23 21 1 ± 25
Famotidine 392 ± 28 201 ± 9
Impromidine 178 ± 22 199 ± 23
HA HA HA PH
PH PH cii HA
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HL-60 membranes. fMLP binding in HL-60 membranes
amounted to 610 ± 21 fmol/mg of protein (mean ± standard
deviation, four experiments). CPH (10 tM to 1 mM) had no
inhibitory effect on fMLP binding (data not shown).
Time courses of the stimulatory effects of CPH on [Ca2]1
are depicted in Fig. 2. In the presence of extracellular Ca2,
CPH rapidly increased [Ca2]1 to a peak that declined to a
sustained plateau above basal values within 2 mm. In the
absence of extracellular Ca2, the magnitude of the CPH-
induced rise in [Ca2] was greatly diminished. The nonselective
cation channel blocker SK&F 96365 [1-(fl-[3-(4-methoxy-
phenyl)propoxy]-4-methoxyphenethyl)-1H-imidazole hydro-
chloride] (30 MM) (3) reduced the stimulatory effect of CPH on
[Ca2]1 in the presence of extracellular Ca2 (see Fig. 2) but not
in its absence (data not shown). Fig. 2 also shows the effect of
CPH on Mn2 influx. At excitation wavelengths of 340 nm and
360 nm, CPH substantially increased the rate of basal Mn2
influx. At the Ca2-sensitive excitation wavelength of 340 nm,
an additional transient increase in fluorescense was evident.
All of these findings indicate that CPH activated both Ca24
mobilization from intracellular stores and Ca24 influx through
nonselective cation channels (1, 3).
Because a part ofthe CPH-induced rise in [Ca24]1 was attrib-
utable to Ca2’ mobilization from intracellular stores (see Fig.
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Fig. 2. Time courses of the stimulatory effects of CPH on [Ca2] and
Mn2 influx in HL-60 cells. HL-60 cells were harvested and loaded with
fura-2/acetoxymethyl ester, and the effects of CPH (1 00 MM) on [Ca2]
(A) and Mn24 influx (B) were assessed as described in Experimental
Procedures. A, Arrow, addition of CPH. Trace 1 , presence of CaCl2 (1
mM) plus solvent (control); trace 2, presence of CaCI2 (1 mM) plus SK&F
96365 (30 MM); trace 3, presence of EGTA (1 mM) without added CaCl2.
B, Experiments were performed without added CaCl2. The emission
wavelength was 500 nm. Arrowhead, addition of MnCl2 (100 MM); arrow,
addition of CPH. Trace 1 , excitation wavelength of 340 nm; trace 2,
excitation wavelength of 360 nm. Superimposed original fluorescence
tracings are shown.
2), we studied the effects of CPH on phospholipase C-catalyzed
inositol phosphate formation. Basal formation of inositol phos-
phate, inositol bisphosphate, and inositol trisphosphate
amounted to 767 ± 38 dpm, 695 ± 37 dpm, and 168 ± 37 dpm,
respectively (means ± standard deviations, three experiments).
CPH (100 MM) increased these values to 924 ± 58 dpm (p <
0.05), 1056 ± 24 dpm (p < 0.05), and 234 ± 24 dpm (p < 0.05),
respectively (means ± standard deviations, three experiments).
Desensitization of CPH- and HA-induced increases in
[Ca24]1 was studied (Fig. 3). HL-60 cells that had been exposed
to HA (100 MM) did not undergo a second rise in [Ca24]1 when
rechallenged with HA (100 MM or 1 mM; data shown only for
100 MM), i.e., the effect of HA was desensitized in a homologous
manner. In contrast, the CPH-induced rises in [Ca24]1 were not
desensitized in a homologous manner. Additionally, there was
no cross-desensitization between HA and CPH.
We also studied the effects of CPH on the formation of
phosphatidylethanol, i.e., a transphosphatidylation product
specifically formed by phospholipase D (21, 27, 28), in HL-60
cells. CPH increased phosphatidylethanol formation by 20%,
and in PTX-treated cells the stimulatory effect of CPH was
abolished (Table 2). fMLP (1 MM) stimulated phosphatidyl-
ethanol formation by about 150%, and this effect was also
sensitive to PTX.
Fig. 4 shows the effects of fMLP and CPH on tyrosine
phosphorylation of 100/110-kDa proteins in HL-60 cells. Table
3 summarizes the densitometric evaluation of the effects of
fMLP and CPH on tyrosine phosphorylation. Experiments
were performed in the absence or presence of CB, which inhibits
actin polymerization and is known to potentiate several re-
sponses to fMLP (1, 4, 29). At an incubation time of 1 mm,
CPH (1 mM) was about 40% less effective than fMLP (10 MM)
in stimulating tyrosine phosphorylation. CB potentiated the
stimulatory effects of fMLP and CPH on tyrosine phosphoryl-
ation. In the presence of CB, fMLP and CPH were similarly
effective in activating tyrosine phosphorylation. At an incuba-
tion time of 3 mm, the stimulatory effects of CPH on tyrosine
500
200
100
 500
200
100-
Fig. 3. Oesensitization of CPH- and HA-induced rises in [Ca24J, in HL-60
cells. HL-60 cells were harvested and loaded with fura-2/acetoxymethyl
ester, and the effects of CPH and HA on [Ca2] were assessed as
described in Experimental Procedures. Arrows, addition of CPH or HA
(1 00 MM each). Original fluorescence tracings are shown.
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TABLE 2
Stimulation by CPH and fMLP of phosphatidylethanol formation in
HL-60 cells and effects of PTX
Pretreatment of HL-60 cells with PTX or carrier (control) was performed as
described in Experimental Procedures. HL-60 cells were harvested and labeled
with [3Hjoleate as described in Experimental Procedures. HL-60 cells were exposed
to PH (1 mM), fMLP (10 MM), or solvent (basal) in the presence of GB (1 Mg/mI)
and 0.5% (v/v) ethanol. Extraction of lipids and detection of radioactive phospha-
tidylethanol were performed as described in Experimental Procedures. The statis-
tical significance of the effects of CPH and fMLP versus solvent on phosphati-
dylethanol formation was assessed as described in Experimental Procedures.
PhosphatidylethanoUonnation
AdditiOn
Contr P-tx
dpm
Solvent (basal) 1429 ± 98 1428 ± 106
CPH 1716±101 1354±156”
fMLP 3546 ± 74 1481 ± 68”
ap < 0.05.
b Not significant.
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Fig. 4. Effects of CPH and fMLP on tyrosine phosphorylation in HL-60
cells. HL-60 cells were exposed to fMLP (10 MM), CPH (1 mM), or solvent
(control), in the absence or presence of CB (1 Mg/mI), for 1 mm (lanes 1-
6) or 3 mm (lanes 7-10). Proteins were analyzed as described in Exper-
imental Procedures. The autoluminogram of an SOS gel containing 9%
(w/v) acrylamide is shown. Lane 1 , solvent (control); lane 2, fMLP; lane
3, fMLP plus CB; lane 4, CB; lane 5, CPH; lane 6, CPH plus CB; lane 7,
solvent (control); lane 8, CPH; lane 9, CPH plus CB; lane 10, CB.
Nummbers on the left and right, molecular masses of marker proteins
(in kOa).
TABLE 3
Densitometric analysis of the stimulatory effects of CPH and fMLP
on tyrosine phosphorylation of 100/11O-kDa proteins in HL-60 cells
HL-60 cells were exposed to fMLP (10 MM), pH (1 mM), or solvent (control), in the
absence or presence of CB (1 Mg/mI), for the indicated periods of time. Proteins
were analyzed as described in Experimental Procedures. The 1 00/1 1 0-kDa regions
of autoluminographs were subjected to densitometnc analysis.
. . . Absorbance of 100/Expenment cOnditionS 110-kDa regiOns
arbitrary units
Solvent (control), 1 mm i .05 ± 0.07
fMLP, 1 mm 1.85 ± 0.15
fMLP + CB, 1 mm 3.20 ± 0.31
CB, 1 mm 1.13 ± 0.08
CPH, 1 mm 1.50 ± 0.13
CPH + CB, 1 mm 3.07 ± 0.34
Solvent (control), 3 mm i .06 ± 0.03
CPH, 3 mm 1.27 ± 0.06
CPH + CB, 3 mm 2.03 ± 0.19
CB, 3 mm i .08 ± 0.09
phosphorylation were already declining. CB by itself did not
significantly stimulate tyrosine phosphorylation.
The effects of CPH and fMLP on O2 formation were corn-
pared. fMLP (1 MM) rapidly activated O2 formation, which
ceased after about 5 mm (Fig. 5A). CB potentiated the stimu-
latory effect of fMLP. CPH (1 mM) did not activate O2
formation in the absence of CB. However, in its presence CPH
(1 mM) activated O2 formation, although with much less
effectiveness than fMLP (1 MM). Fig. SB shows the concentra-
tion-response curve for the stirnulatory effects of CPH on O2
formation in the presence of CB. CPH activated O2 formation
with an EC50 of 0.65 mM and a plateau at 1-2 mM. Clemastine
and famotidine (10 MM each) had no inhibitory effect on CPH-
induced O2 formation (data not shown). In PTX-treated cells,
CPH did not activate O2 formation.
Fig. 6 shows the effects of fMLP and CPH on enzyme release
in HL-60 cells. fMLP stimulated azurophilic granule release
with an EC50 of 15 nM and a maximum at 0.1-1.0 MM. CPH
activated fl-glucuronidase release with an EC50 of 0.15 mM and
a maximum at 0.3-1.0 mM. CPH was less effective than fMLP
in stimulating azurophilic granule release. fMLP and CPH had
no stimulatory effect on the release of the cytosolic enzyme
lactate dehydrogenase. In addition, CPH and fMLP did not
stimulate uptake of the dye trypan blue into HL-60 cells (data
not shown). The latter two findings indicate that CPH was not
cytotoxic at the concentrations studied.
Next, we studied the effects of CPH and fMLP on high
affinity GTP hydrolysis, i.e., the enzymatic activity of G protein
a subunits, and on GTP’YS binding in HL-60 membranes. The
Km of basal high affinity GTPase in HL-60 membranes was
0.43 ± 0.08 MM (mean ± standard deviation, three experiments).
As is the case for fMLP (9), CPH increased the Vmsx of GTP
hydrolysis without affecting the Km (data not shown), inclicat-
ing that the substance increased the catalytic rate of GTP
turnover. CPH activated high affinity GTP hydrolysis and
GTPYS binding with an EC50 of about 0.3 mM and a maximum
at 1-3 mM (Fig. 7). Clernastine and famotidine (10 MM each)
had no effect on CPH-stimulated GTP hydrolysis in HL-60
membranes (data not shown).
Table 4 compares the stirnulatory effects of fMLP (10 MM)
and CPH (1 mM) on high affinity GTP hydrolysis in HL-60
membranes. In control membranes, fMLP increased GTP hy-
drolysis and GTPYS binding by about 150%. CPH was about
50% less effective than fMLP in stimulating GTPase and
GTPYS binding. Pretreatment with PTX resulted in almost
complete or complete inhibition of the stimulatory effects of
CPH and fMLP on GTP hydrolysis and GTPYS binding.
N-Ethylmaleinimide alkylates G1 protein a subunits and
thereby uncouples receptors from G proteins in a manner
similar to that of PTX-catalyzed ADP-ribosylation (30). Pre-
treatment of HL-60 membranes with N-ethylmaleinimide re-
duces the stimulatory effect of fMLP on GTPase by about 40%
(9). The stimulatory effect of CPH (1 mM) on GTP hydrolysis
was reduced from 70% in control membranes to 15% in N-
ethylmaleinimide-treated membranes (data not shown).
fMLP not only stimulated GTP hydrolysis and GTPyS
binding in HL-60 membranes in a PTX-sensitive manner but
also stimulated the incorporation of GTP azidoanilide into,
and CTX-catalyzed ADP-ribosylation of, 40/41-kDa proteins
(representing G1 protein a subunits) in HL-60 membranes (Fig.
8) (9). Densitometric analysis revealed that fMLP increased
photolabeling by 53 ± 18% (mean ± standard deviation, three
experiments). Compared with fMLP, CPH was about 50% less
effective in stimulating photolabeling (26 ± 15% stimulation,
mean ± standard deviation, three experiments) (see Fig. 8A).
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Fig. 6. Effects of CPH and fMLP on enzyme release in HL-60 cells. HL-
60 cells were harvested and enzyme release was determined in the
presence of CPH or fMLP at the indicated concentrations, as described
in Experimental Procedures. Reaction mixtures contained CB (1 Mg/mI).
., 9-GIucuronidase release; #{149},lactate dehydrogenase release.
As was the case for photolabeling, CPH (1 mM) was less
effective than fMLP in enhancing CTX-catalyzed ADP-ribo-
sylation of G protein a subunits in HL-60 membranes (see Fig.
8B).
Discussion
To clarify the functional relevance of H1 receptors in dibu-
tyryl-cAMP-differentiated HL-60 cells (2), we studied the ef-
fects of CPH, one of the most potent and selective H1 receptor
agonists presently available (12, 13), in these cells. We found
that CPH, similarly to HA, activates phospholipase C, Ca24
mobilization, and nonselective cation channels (see Figs. 1-3)
(2). Additionally, HA and CPH are less effective than fMLP in
inducing increases in [Ca2], (see Fig. 1) (2). In view of our
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Fig. 5. Effects of CPH and fMLP on
 O2 formation in HL-60 cells. HL-60
l cells were harvested and O2 for-
 mation was assessed under various
p- experimental conditions, as de-
 scnbed in Experimental Procedures.
 A, Time course of 02 formation.
Arrow, addition of stimuli. Experi-
__ ments were performed in the ab-
 sence or presence of CB (1 Mg/mI).
. Trace 1, fMLP (1 MM) plus CB; trace
 2, fMLP (1 MM); trace 3, CPH (1 mM)
plus CB; trace 4, CPH (1 mM). Su-
perimposed original spectrophoto-
I4 metric recordings are shown. B,
0 Concentration-response curves for
CPH-induced O2 formation. Cells
were treated with PTX or carrier
(control) as described in Experimen-
tal Procedures. , Control cells;#{149},
PTX-treated cells.
original assumption that CPH is an H1 receptor agonist not
only in the guinea pig ileum and in DDT1MF-2 cells but also
in HL-60 cells, these findings were not unexpected.
Most unexpectedly, however, we noticed several differences
in the effects of HA and CPH in HL-60 cells. The effects of
CPH on [Ca24], were abolished by PTX, whereas those of HA
were only partially PTX sensitive (see Fig. 1) (2). These data
indicate that only G proteins are involved in the signal trans-
duction pathway activated by CPH. Additionally, in the guinea
pig ileum and in DDT1MF-2 cells CPH is a similarly potent H1
receptor agonist, compared with HA, whereas in HL-60 cells
CPH is approximately 10-fold less potent than HA in increasing
[Ca24]1 (see Fig. 1) (2, 12, 13). Moreover, there are differences
in the kinetics of HA- and CPH-induced increases in [Ca2j,
(see Figs. 2 and 3) (2). Other differences between HA and CPH
4 ; were observed with respect to activation oftyrosine phosphoryl-
ation, O2 formation, and azurophilic granule release, i.e., Un-
c (-log N) like HA, CPH was stimulatory (see Figs. 4-6) (2). Most impor-
tantly, the stimulatory effects of CPH on [Ca2],, 02 formation,
and GTPase were completely resistant to inhibition by various
HA receptor antagonists (see Table 1). Finally, the CPH-
induced rises in [Ca24],, unlike the HA-induced increases, were
not subject to homologous desensitization, and there was no
cross-desensitization between HA and CPH (see Fig. 3). From
all of these data we conclude that CPH activates HL-60 cells
through a mechanism that is independent of known HA recep-
tor subtypes.
Why does CPH not act as an H1 receptor agonist in HL-60
cells although these cells express functional H1 receptors (see
Table 1) (2) and although CPH has been shown to be a potent
H1 receptor agonist in at least two systems (12, 13)? An
explanation for these discrepancies may be that there are
different H1 receptor reserves in the systems studied. Specifi-
cally, the H1 receptor reserve in DDT1MF-2 cells is apparently
lower than that in the guinea pig ileum (13). In the former
system, unlike in the latter, CPH is only a partial H1 receptor
agonist (13). Possibly, the H1 receptor reserve in HL-60 cells is
Fig. 7. Concentration-response
curves for the stimulatory effects of
CPH on GTP hydrolysis and GTP-yS
binding in HL-60 membranes. GTP
hydrolysis and GTP-yS (GTP[SJ)
binding in HL-60 membranes were
determined in the presence of CPH
at the indicated concentrations, as
described in Experimental Proce-
dures.
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TABLE 4
Effect of PTX on stimulation of GTP hydrolysis and GTPyS binding
caused by CPH and fMLP in HL-60 membranes
Pretreatment of HL-60 cells with PTX or carrier (control) was performed as
described in Experimental procedures. GTP hydrolysis and GTP-YS binding in HL-
60 membranes were determined in the presence of CPH (1 mM), fMLP (10 MM), or
solvent (basal), as descnbedinExperimental Procedures.
GTP hydrolysis GTPyS nding
COntrol PTX COntrol PTX
pmol/rng/min pool/mg
Solvent (basal) 17.5 ± 0.7 10.3 ± 0.2 1.27 ± 0.10 0.99 ± 0.05
CPH 30.1 ± 1 .3 9.0 ± 0.5 2.08 ± 0.09 0.93 ± 0.06
fMLP 43.1 ± 0.6 10.6 ± 0.3 3.16 ± 0.17 1.02 ± 0.03
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Fig. 8. Effects of CPH and fMLP on incorporation of GTP azidoanilide
into, and CTX-catalyzed AOP-ribosylation of, G protein a subunits in HL-
60 membranes. A, Photolabeling was performed as described in Exper-
mental Procedures. The autoradiogram of an SOS gel containing 4 M
urea and 9% (w/v) acrylamide is shown. Lane 1, solvent (control); lane
2, fMLP (1 0 MM); lane 3, CPH (1 mM). B, ADP-ribosylation was performed
as described in Experimental Procedures. The autoradiogram of an SOS
gel containing 10% (w/v) acrylamide is shown. Lane 1 , solvent (control);
lane 2, CPH (1 mM); lane 3, fMLP (1 0 MM). Numbers on the left, molecular
masses of marker proteins (in kOa). OF, dye front.
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even lower than that in DDT1MF-2 cells, so that the expected
agonistic effect of CPH at H1 receptors in HL-60 cells is too
small to be detected. Thus, instead of activating H1 receptors
in HL-60 cells, CPH apparently interacts with a different site,
which may be an as yet unknown HA receptor subtype. Al-
though CPH mimicked many of the effects of fMLP in intact
HL-60 cells and in HL-60 membranes (see Figs. 1 and 4-8 and
Tables 2-4) (1-9), it is very unlikely that the substance acts as
a formyl peptide receptor agonist, because it did not compete
with fMLP for binding.
Another possible mechanism of action of CPH could be that
this substance activates G proteins directly, i.e., in a receptor-
independent manner. It is well known that various cationic-
amphiphilic substances, such as substance P, compound 48/80,
and the wasp venom mastoparan, stimulate G proteins in such
a way (14, 15). In fact, CPH also is a cationic-amphiphilic
substance. Specifically, CPH possesses a hydrophobic halogen-
substituted phenyl residue and a basic domain (see Fig. 1) (12).
At pH 7.2-7.4 (the pH values of buffers used in the various
assays; see Experimental Procedures), the amino group of CPH
is, for the most part, positively charged (12, 31, 32). In accord-
ance with this suggested mode of action of CPH may be our
finding that the concentrations of the substance required to
activate G, proteins are higher than those needed for stimula-
tion of H1 receptors (see Figs. 1 and 5-7) (12, 13).
fMLP is about S-fold more potent in increasing [Ca2’]1 than
in activating O2 formation and azurophilic granule release (1,
2, 4, 5). Two formyl peptide receptor subtypes have been
identified at the cDNA level in dibutyryl-cAMP-differentiated
HL-60 cells (33), but it is still unknown, inasmuch as different
formyl peptide receptor subtypes are responsible for mediating
rises in [Ca24]1 on one hand and activation of O2 formation
and enzyme release on the other (5). Because the differences
in amino acid sequences of formyl peptide receptors in HL-60
cells are only small (33), one could also envisage that the
differences in potency of fMLP with respect to the aforemen-
tioned parameters are attributable to differential requirements
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for the number of activated G, proteins, rather than being due
to activation of different receptor subtypes. If stimulation of
increases in [Ca24], required a smaller number of activated G,
proteins than did stimulation of 02 formation and azurophilic
granule release, CPH would be expected to be more potent with
respect to the former parameter than with respect to the latter
two. This is, in fact, the case (see Figs. 1, 5, and 6).
Stimulation of tyrosine phosphorylation is thought to play a
role in the activation of O2 formation caused by fMLP (8, 34).
We found that CPH substantially activated tyrosine phos-
phorylation in the absence of CB but failed to activate O2
formation in its absence (see Figs. 4 and 5 and Table 3). In
addition, fMLP and CPH are similarly effective activators of
tyrosine phosphorylation in the presence of CB, but CPH is a
considerably less effective activator of O2 formation than is
fMLP under these conditions (see Figs. 4-6 and Table 3). These
findings may indicate that tyrosine phosphorylation is not
sufficient for activation of 02 formation and that activation
of additional effector systems, e.g., phospholipase D, is required
(35).
In conclusion, we have shown that CPH activates G, proteins
in dibutyryl-cAMP-differentiated HL-60 cells through a recep-
tor agonist-like mechanism that is independent of known HA
receptor subtypes and formyl peptide receptors. Future studies
will have to answer the question of whether CPH is an agonist
at an as yet unknown HA receptor subtype or activates G
proteins directly. In addition, the structure-activity relation-
ships of 2-substituted HA derivatives with respect to G, protein
activation in HL-60 cells have to be determined. Future studies
will have to take into consideration the fact that CPH, in
addition to activating H1 receptors, may show other, most
unexpected, stimulatory effects on G protein-mediated signal
transduction processes.
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